Catalyst Wire Dossier Catalyst Wire Dossier

GABARONE

GABAPENTIN · INA Pharmaceutics Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GABARONE, covering 2024-03-04 to 2025-09-05. Get the full timeline:

Most recent: FDA Approved: GABARONE — Supplemental Application (INA Pharmaceutics Inc.)

See pricing